Table 4.
Indicators of international collaboration
“Live-pathogen” research |
“Non-pathogen” research |
|||||
1997–2001 | 2003–2007 | Change | 1997–2001 | 2003–2007 | Change | |
Fraction of papers involving at least one US and one non-US institution | ||||||
B. anthracis | 16% | 20% | 22% | 21% | 11% | −48%** |
Ebola virus | 23% | 38% | 63%* | 50% | 36% | −29% |
K. pneumoniae | 26% | 33% | 25%* | 24% | 53% | 124%** |
Share of degree centrality of all non-US institutions | ||||||
B. anthracis | 18% | 26% | 44% | 26% | 26% | 0% |
Ebola virus | 32% | 28% | −13% | 24% | 39% | 63% |
K. pneumoniae | 37% | 39% | 6% | NS | 50 | NS |
Share of papers involving exclusively US collaborations | ||||||
B. anthracis | 39% | 57% | 46%* | 25% | 40% | 62%*** |
Ebola virus | 42% | 44% | 4% | 45% | 29% | −37% |
K. pneumoniae | 30% | 30% | −1% | 21% | 5% | −74%† |
NS, indicates an insufficient number of institutions to calculate share of degree centrality. *P ≤ 0.10, **P ≤ 0.05, ***P ≤ 0.01.
†Significance test impossible due to small sample size.